Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Innovent Announces Primary Endpoint Met in Phase 2 of IBI302 in Neovascular AMD Treatment
Details : AVA1014 (ferric citrate coordination complex) is an iron containing phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis.
Product Name : AVA1014
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
April 23, 2024
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable